At 68 weeks, average body weight had fallen by 15.0%, total fat mass by 19.3% and regional visceral fat by 27.4%
[14] Around 15% of MG patients lack detectable serum AChR antibodies
Injection site reactions, including bruising, are documented adverse effects in semaglutide clinical trials, though bruising is not separately reported in FDA labeling
Given the scarcity of available evidence for the effects of T2D treatment on CV outcomes in women and the increased emphasis on CV risk reduction [2], additional analysis of CV outcome trials in T2D by gender could help individualize optimal care and risk management for all patients with a history of or risk factors for CVD
Orngreen MC, Olsen DB, Vissing J: Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose
Current details sit on Noom's official website